INTELLECTUAL PROPERTY
TGC Network’s core technology is protected by issued U.S. patents, including:
- United States Patent No. 11,179,340 B2
- United States Patent No. 12,220,488 B2
Patented Products
These patents cover novel formulations and delivery mechanisms for cannabinoid-based compounds in solid oral dosage forms.
International protections underway